• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人外周血源性 CD34+细胞体外生产红细胞的潜力。

The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production.

机构信息

School of Chemical and Bioprocess Engineering, and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

出版信息

J Biotechnol. 2009 Oct 26;144(2):127-34. doi: 10.1016/j.jbiotec.2009.08.017. Epub 2009 Sep 6.

DOI:10.1016/j.jbiotec.2009.08.017
PMID:19735679
Abstract

The potential of peripheral blood derived CD34+ cells for ex vivo erythropoiesis was investigated in a stroma-free culture system using a novel strategy of daily passaging. By expanding PB-derived CD34+ cells up to 1.5 x 10(6)-fold this method achieved expansion factors previously only reported for CD34+ cells derived from more potent stem cell sources such as cord blood, bone marrow and mobilized peripheral blood. Analysis of cell surface markers showed differentiation of immature CD34+ cells to populations with 80% CD71-/GpA+ cells and up to 45% enucleated cells, indicating a significant amount of terminal maturation. Cell crowdedness was found to have decisive effects on in vitro erythropoiesis. Cell density per surface area rather than cell concentration per media volume determined cell expansion during exponential growth where more crowded cells showed reduced overall expansion. In late stage erythropoiesis, however, when cells no longer proliferating, increased cell density was seen to enhance cell viability. These results indicate that peripheral blood derived haematopoietic stem cells can be an alternative to cells sourced from bone marrow, cord blood or leukapheresis in terms of expansion potential. This provides distinct advantages in terms of availability for studies of conditions for scale-up and maturation, and may have particular clinical applications in the future.

摘要

研究了在无基质培养体系中,通过每日传代的新策略,外周血来源的 CD34+细胞在外周血来源的 CD34+细胞体外红系生成中的潜力。通过将 PB 来源的 CD34+细胞扩增至 1.5 x 10(6)-倍,该方法实现了以前仅在更有效的干细胞来源(如脐带血、骨髓和动员外周血)中报告的 CD34+细胞的扩增倍数。细胞表面标志物分析表明,未成熟的 CD34+细胞分化为具有 80% CD71-/GpA+细胞和高达 45%去核细胞的群体,表明存在大量终末成熟。细胞拥挤度被发现对体外红系生成有决定性影响。细胞密度与表面积的比值而不是细胞浓度与培养基体积的比值决定了指数生长期间的细胞扩增,其中更拥挤的细胞显示出整体扩张减少。然而,在晚期红系生成中,当细胞不再增殖时,增加细胞密度被认为可以提高细胞活力。这些结果表明,外周血来源的造血干细胞在扩增潜力方面可以替代骨髓、脐带血或白细胞分离物来源的细胞。这在可用于扩大规模和成熟条件的研究方面提供了明显的优势,并可能在未来具有特殊的临床应用。

相似文献

1
The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production.人外周血源性 CD34+细胞体外生产红细胞的潜力。
J Biotechnol. 2009 Oct 26;144(2):127-34. doi: 10.1016/j.jbiotec.2009.08.017. Epub 2009 Sep 6.
2
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.巨核细胞祖细胞的体外扩增:多种生长因子组合对来自骨髓和粒细胞集落刺激因子动员的外周血的CD34+祖细胞的影响。
Exp Hematol. 1997 Oct;25(11):1125-39.
3
In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems.利用两种不同的细胞培养系统,将人外周血中的CD34+细胞在体外增殖并分化为成熟红细胞。
Transfusion. 2008 Jun;48(6):1122-32. doi: 10.1111/j.1537-2995.2008.01653.x. Epub 2008 Feb 22.
4
Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels.确定人脐带血细胞体外扩增的最佳条件。祖细胞富集、对饲养层的干扰、早期作用细胞因子及培养容器搅拌的影响。
Stem Cells. 1999;17(1):19-24. doi: 10.1002/stem.170019.
5
Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.从人骨髓、外周血和脐带血中获取、鉴定及培养CD34+细胞。
Blood Cells. 1994;20(2-3):411-23.
6
Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.长期造血培养起始细胞在动员的外周血移植物中比在骨髓中更为丰富,但体外扩增潜力更有限。
Blood Cells Mol Dis. 1996;22(1):68-81. doi: 10.1006/bcmd.1996.0010.
7
Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.细胞因子诱导的人CD34+干/祖细胞和培养于正常成骨细胞上的CD34+CD41+早期巨核细胞骨髓细胞的扩增。
Stem Cells. 1999;17(2):92-9. doi: 10.1002/stem.170092.
8
Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.响应干细胞因子,细胞周期的G0/G1期快速退出赋予脐带血CD34+细胞增强的体外扩增潜能。
Exp Hematol. 1994 Dec;22(13):1264-72.
9
Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer.使用泊洛沙姆 188 作为红细胞存活增强剂,无基质大规模生产临床级红细胞(RBC)。
Transfusion. 2009 Nov;49(11):2285-95. doi: 10.1111/j.1537-2995.2009.02303.x. Epub 2009 Jul 10.
10
[In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].[体外生成成熟且有功能的人类红细胞:一个具有多学科视角的模型]
Bull Acad Natl Med. 2005 May;189(5):903-13; discussion 914-5.

引用本文的文献

1
Humanized Culture Medium for Clinical-Grade Generation of Erythroid Cells from Umbilical Cord Blood CD34 Cells.用于从脐带血CD34细胞临床级生成红系细胞的人源化培养基。
Adv Pharm Bull. 2021 Feb;11(2):335-342. doi: 10.34172/apb.2021.031. Epub 2020 Feb 29.
2
BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.BMI1 可使来自人外周血单个核细胞的功能性成红细胞大量扩增。
Mol Ther. 2021 May 5;29(5):1918-1932. doi: 10.1016/j.ymthe.2021.01.022. Epub 2021 Jan 21.
3
Plant cell-secreted stem cell factor stimulates expansion and differentiation of hematopoietic stem cells.
植物细胞分泌的干细胞因子可刺激造血干细胞的扩增和分化。
Process Biochem. 2021 Jan;100:39-48. doi: 10.1016/j.procbio.2020.09.029. Epub 2020 Sep 25.
4
In Vitro Generation of Red Blood Cells from Stem Cell and Targeted Therapy.体外从干细胞和靶向治疗生成红细胞。
Cell Transplant. 2020 Jan-Dec;29:963689720946658. doi: 10.1177/0963689720946658.
5
Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells.从人外周血单个核细胞大规模体外生产红细胞。
Blood Adv. 2019 Nov 12;3(21):3337-3350. doi: 10.1182/bloodadvances.2019000689.
6
Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies.纯红:一种新型分光光度法红细胞增殖测定法,作为红细胞生成和红细胞毒性研究的工具。
Biotechnol Rep (Amst). 2014 Jul 24;4:34-41. doi: 10.1016/j.btre.2014.07.005. eCollection 2014 Dec.
7
Superior survival of cultured human reticulocytes following transfusion into mice.将培养的人网织红细胞输注到小鼠体内后具有更高的存活率。
Haematologica. 2017 Mar;102(3):476-483. doi: 10.3324/haematol.2016.154443. Epub 2016 Dec 1.
8
Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down.通过敲低SOCS3促进造血干细胞的红细胞生成分化
PLoS One. 2015 Aug 7;10(8):e0135259. doi: 10.1371/journal.pone.0135259. eCollection 2015.
9
Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.人诱导多能干细胞的红系分化与起源的供体细胞类型无关。
Haematologica. 2015 Jan;100(1):32-41. doi: 10.3324/haematol.2014.108068. Epub 2014 Oct 17.
10
Erythropoietic potential of CD34+ hematopoietic stem cells from human cord blood and G-CSF-mobilized peripheral blood.人脐带血和粒细胞集落刺激因子动员的外周血中CD34+造血干细胞的红细胞生成潜能。
Biomed Res Int. 2014;2014:435215. doi: 10.1155/2014/435215. Epub 2014 May 5.